What stands out is that Nextracker is not a speculative solar name anymore; it is already a very high-quality earnings machine. Revenue has gone from $1.46B in FY2022 to $3.56B in FY2026, a 2.4x increase in four years, while net income went from effectively breakeven to $585.9M. Even more important, this was not bought with margin sacrifice. Gross margin improved from 10.1% in FY2022 to 32.6% in FY2026, operating margin from 4.5% to 19.6%, and net margin to 16.5%. Quarterly results show some lumpiness in revenue, but not a business losing control: the last four quarters were $864.3M, $905.3M, $909.4M, and $880.5M, while net margins stayed in a very healthy 14.4%-18.2% range. A solar equipment company producing over $500M of annual FCF on just $49.3M of capex, with $1.09B cash and no debt, deserves a premium to industrial peers.

The core question is whether that premium should still be this large at $101.47. On trailing numbers, the market is paying about 26.4x earnings, 19.1x EV/EBITDA, and roughly 30x FCF for a business that just grew revenue 20.3% and earnings 15.1%. That is not obviously insane, but it is rich for a company whose near-term revenue has flattened sequentially around the $880M-$925M quarterly band. FY2026 revenue rose 20% to $3.56B, but operating income only rose 9% from $639.1M to $697.3M, suggesting the easy operating leverage phase is fading. The annual numbers show a major structural step-up from FY2023 to FY2024, then much more incremental gains after that. To me, the story the numbers tell is less “early innings hyper-growth compounder” and more “excellent cyclical category leader now entering a steadier, more mature earnings phase.” If that framing is right, a low-20s earnings multiple is defendable; a high-20s/30x FCF setup leaves limited room for solar project timing hiccups, policy noise, or tracker pricing pressure.

That is why I do not get to the extreme bearishness implied by a fair value in the low-$50s. A company earning $585.9M with net cash of about $1.09B and converting 88% of net income into FCF ($513.6M / $585.9M) should not trade like a generic cyclical fabricator. Even if one haircut margins from the current 16%-18% quarterly net margin zone toward, say, 13%-14%, the business would still be very profitable on a multi-billion-dollar revenue base. The balance sheet sharply reduces downside because there is no leverage amplifying a sector downturn. In other words, the raw data argue against both the “commodity tracker” dismissal and the “software platform” fantasy. This looks like a superior industrial franchise with real moat elements, but not one that merits paying almost any price.

The best counterargument to my caution is that the last three years have repeatedly made valuation skeptics look foolish. Revenue has compounded at roughly 19%, earnings much faster, and FY2026 still posted 20% top-line growth on a base already above $2.9B. Gross profit reached $1.16B, and margins have held remarkably steady despite scale, which is exactly what you would expect if product differentiation and execution are real rather than narrative fluff. A bull would also note that 26x trailing earnings is not demanding if the company can keep compounding EPS at mid-teens rates while carrying excess cash and no debt. If utility-scale solar deployment remains structurally strong, today’s multiple could compress naturally through growth rather than price decline. I weigh that argument less heavily because the quarterly revenue cadence already looks more mature than the bull case wants to admit, and mature businesses with policy and project-cycle exposure rarely hold premium multiples indefinitely.

What would change my mind is simple. I would turn constructive if Nextracker reaccelerates from this $900M-ish quarterly plateau and proves FY2027 can deliver another leg up without margin erosion — specifically, sustained quarterly revenue above $950M and net margins still above 15%, or annual FCF moving decisively toward $650M+. That would support the premium as earned rather than narrative-driven. I would turn outright bearish if revenue slips back toward the $700M-$800M range while gross margin falls below 30% or operating margin drops under 17%; in that case, the market would likely stop treating this as a quality compounder and start valuing it like a cyclical equipment supplier. At $101, I see a great company, but not a cheap stock.